Investors / United States / Lifespan Vision Ventures
Lifespan Vision Ventures
Venture capital · Norwalk, CT, United States · North America
Lifespan Vision Ventures is an investment firm that backs companies developing therapeutics and platforms aimed at aging and age-related disease. It pairs capital with scientific expertise and a network across academic institutions, biotech operators and financial markets.
Invests inHealthcare & Biotech
In its own wordslongevitybiotechagingtherapeuticsdrug discoverylife sciences
Your fit with Lifespan Vision Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsLifespan Vision Ventures lists 23 checked portfolio companies on its own site and is named in 4 funding rounds, 3 of them as lead. Its most frequent entry is Seed, 75% of the companies with a known first round. Its largest theme is Healthcare & Biotech (100%). 80% of its companies are based in United States. It invests most often alongside quadraScope Ventures, Y Combinator and Bold Capital Partners.
Counts come from funding rounds that name Lifespan Vision Ventures, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Lifespan Vision Ventures' whole history. Rounds on record name 4 companies; its own site lists 23. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 75% |
| Series A | 25% |
| Series B | 0% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 0 | 0 |
| '26 | 4 | 3 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 57th | 23 companies |
| Recent activity | 82th | 4 rounds in 12 months |
| Early stage | 82th | 75% of entries at pre-seed or seed |
| Evidence | 89th | 17% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 59th | 3 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| quadraScope Ventures | 4 |
| Y Combinator | 3 |
| Bold Capital Partners | 2 |
| Eos BioInnovation | 2 |
| Jetstream Venture Fund | 2 |
| 99 Startups | 1 |
| APEX Ventures | 1 |
| Augurey Ventures | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers23100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with quadraScope Ventures
Compare Lifespan Vision Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Lifespan Vision Ventures| Date | Company | Stage |
|---|---|---|
| 10 Aug 2026 | Series A Led | |
| 13 May 2026 | Seed Led | |
| 18 Feb 2026 | Seed Led | |
| 8 Jan 2026 | Seed |
Round details for Lifespan Vision Ventures
Amounts, full round histories and every co-investor in Lifespan Vision Ventures' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
23 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Algen Biotechnologies discovers medicines through advanced CRISPR gene-modulation and AI | Healthcare & Biotech | Portfolio page | ||
| BIOIO develops gerotherapies targeting aging at its core to extend health-span and longevity | Healthcare & Biotech | Portfolio page | ||
| Bolden Therapeutics is developing therapies to increase neurogenesis for improving outcomes in neurological diseases | Healthcare & Biotech | Portfolio page | ||
| Deciduous Therapeutics develops novel medicines to eliminate senescent cells and treat age-related diseases. | Healthcare & Biotech | Portfolio page | ||
| EpiBone grows personalized bone and cartilage products using stem cells for repair and healing | Healthcare & Biotech | Portfolio page | ||
| Fauna Bio is an AI-driven drug discovery company that leverages data from 100 million years of evolved disease resistance in mammals to create new drugs for humans. | Healthcare & Biotech | Portfolio page | ||
| General Proximity develops programmable medicines based on proximity mechanisms to control biology | Healthcare & Biotech | Portfolio page | ||
| Immunis Biomedical is a clinical-stage biotech developing therapeutics targeting age-related disease | Healthcare & Biotech | Portfolio page | ||
| The company generates and utilizes multimodal aging datasets and AI-driven drug discovery for age-related disease | Healthcare & Biotech | Portfolio page | ||
| Lift Therapeutics develops cell therapies designed to directly kill tumor cells and re-ignite anti-tumor immunity in cancer patients | Healthcare & Biotech | Portfolio page | ||
| Matter Bio has developed a clinical-stage next generation immuno-oncology platform designed to recruit memory T cells into the hardest-to-treat solid tumors. | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| The company develops drugs that enhance the neuroimmune system to treat neurological conditions. | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Paulex Bio is working on a cure for type 1 and type 2 diabetes through beta cell regeneration | Healthcare & Biotech | Portfolio page | ||
| PriveBio develops next-generation therapeutics for the treatment of obesity-related co-morbidities and fibroinflammatory diseases | Healthcare & Biotech | Portfolio page | ||
| Rejuvenate Bio develops gene therapy treatments for chronic age-related diseases in animals and humans. | Healthcare & Biotech | Portfolio page | ||
| Rejuvenation Technologies Inc develops therapeutic technologies to lengthen telomeres in human cells, aiming to reverse cellular aging and prevent or treat diseases caused by short telomeres. | Healthcare & Biotech | Portfolio page | ||
| Remedium is a biotechnology company focused on developing treatments for diseases with significant unmet clinical needs using gene therapy technologies. | Healthcare & Biotech | Aug 2026Series A | Page + round | |
| SENISCA is a biotech company focused on modulating RNA biology to treat age-related disease. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- lifespanvisionventures.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 8 Jan 2026
- Companies checked
- 23
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Lifespan Vision Ventures' profile as data
Pull Lifespan Vision Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/lifespanvisionventures.com
# also
GET /v1/firms/lifespanvisionventures.com/portfolio
GET /v1/firms/lifespanvisionventures.com/coinvestors
GET /v1/firms/lifespanvisionventures.com/news